Propranolol Dosing for Intention Tremor
The evidence provided does not support propranolol for intention tremor specifically—propranolol is effective for essential tremor (action/postural tremor), not intention tremor (cerebellar tremor). This is a critical distinction that affects treatment decisions and outcomes.
Understanding the Distinction
Intention tremor is a cerebellar sign that worsens during goal-directed movement (finger-to-nose testing) and indicates cerebellar pathway dysfunction. Essential tremor is an action/postural tremor that occurs during voluntary muscle contraction or maintaining a posture against gravity.
If You Actually Mean Essential Tremor:
For essential tremor, start propranolol at 40 mg twice daily (80 mg/day total) and titrate up to 120-320 mg/day in divided doses based on response and tolerability 1.
Dosing Algorithm:
- Starting dose: 40 mg twice daily or 60 mg three times daily (total 80-180 mg/day)
- Titration: Increase by 40-80 mg every 3-7 days as tolerated
- Target dose: 120-240 mg/day in 2-3 divided doses 2, 3
- Maximum dose: 320 mg/day (higher doses rarely provide additional benefit) 4
- Optimal response: Usually achieved at 160 mg/day for most patients 4
Evidence-Based Recommendations:
The 2011 American Academy of Neurology guideline establishes propranolol as Level A (established as effective) for essential tremor 1. Multiple controlled trials demonstrate 40-65% reduction in tremor amplitude at doses of 120-240 mg/day 5, 3.
Key dosing principles:
- Higher doses (240 mg/day) are significantly more effective than lower doses (120 mg/day) 5
- Long-acting formulations (160-320 mg once daily) are equally effective as divided dosing 6, 4
- Response correlates with baseline tremor amplitude—patients with larger amplitude tremors respond better (65% reduction vs 17% in small amplitude tremors) 5
Practical Considerations:
Contraindications to screen for:
- Asthma or reactive airway disease (absolute)
- Heart block (second or third degree)
- Decompensated heart failure
- Hypoglycemia risk (use caution, not absolute)
Monitoring requirements:
- Baseline heart rate and blood pressure
- No routine ECG needed unless cardiac history or abnormal vital signs
- Assess response at 3-4 weeks on stable dose 2
Expected timeline:
- Initial response: 1-4 hours after first dose 7
- Full therapeutic effect: 3-4 weeks at target dose 2
- If no response after 3 months at 120 mg/day, consider increasing to 240 mg/day before discontinuing 2
Response Predictors:
Better response expected with:
- Age <60 years (especially <35 years) 2
- Tremor duration <12 years 2
- Larger baseline tremor amplitude 5
- Upper extremity tremor (head/voice tremor responds poorly) 8
Poor response expected with:
- Age >60 years (no excellent responses documented) 2
- Small amplitude tremors at baseline 5
- Axial tremors (head, voice) 8
If You Actually Mean Cerebellar Intention Tremor:
For true intention tremor from cerebellar disease (multiple sclerosis, stroke, spinocerebellar ataxia), propranolol has limited evidence. One recent 2025 trial in spinocerebellar ataxia type 12 showed benefit with extended-release propranolol up to 240 mg/day, escalated by 40 mg weekly 9. However, this remains investigational for cerebellar tremors.
Common pitfall: Clinicians often confuse essential tremor (which propranolol treats effectively) with intention tremor (cerebellar, which propranolol does not reliably treat). Always confirm tremor type with examination—intention tremor worsens during finger-to-nose testing and indicates cerebellar pathology requiring different management approaches.